Greg has a PhD in molecular immunology with more than 25 years of experience in biopharmaceutical R&D with managerial experience in drug development.

Greg’s initial experience was in biologics product discovery and technology platform development. Subsequently, he moved into a product leadership role whilst concomitantly building cross-functional teams within the Biologics CMC departments that he headed. Greg’s current experience in biologics development leadership (teams/projects/products) was progressively gained through management roles within cutting edge biologics development organizations such as NovImmune and Glenmark.